| ¿µ¹® | symptomatic therapy | ÇÑ±Û | ´ëÁõ¿ä¹ý |
|---|---|---|---|
| ¼³¸í | º´ÀÇ ¿øÀÎÀ» ã¾Æ ¾ø¾Ö±â °ï¶õÇÑ »óȲ¿¡¼, °ÑÀ¸·Î ³ªÅ¸³ º´ÀÇ Áõ»ó¿¡ ´ëÀÀÇÏ¿© óġ¸¦ ÇÏ´Â Ä¡·á¹ý. ¿ÀÌ ³ôÀ» ¶§¿¡ ¾óÀ½ÁָӴϸ¦ ´ë°Å³ª ÇØ¿Á¦¸¦ ½á¼ ¿À» ³»¸®°Ô ÇÏ´Â µûÀ§°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. |
||
| ¿µ¹® | radiation therapy | ÇÑ±Û | ¹æ»ç¼±¿ä¹ý |
|---|---|---|---|
| ¼³¸í | X¼±, ¥ã¼±ÀÇ ÀüÀÚ¹æ»ç¼±À̳ª ÀüÀÚ¼±, ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÇ ÀÔÀÚ¹æ»ç¼±À» ÀÌ¿ëÇØ, ÁÖ·Î ¾Ç¼º Á¾¾ç Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÏ´Â Ä¡·á¹ýÀÌ´Ù. ¾Ï¼¼Æ÷°¡ ÁÖÀ§ÀÇ Á¤»ó¼¼Æ÷º¸´Ùµµ ¹æ»ç¼± °¨¼ö¼ºÀÌ ³ôÀº Á¡À» ÀÌ¿ëÇÏ¿©, Á¤»ó¼¼Æ÷ÀÇ ¼Õ»óÀ» °¡´ÉÇÑ ÇÑ ÃÖ¼Ò·Î ¾ïÁ¦ÇÏ¸é¼ ¾Ï¼¼Æ÷¸¦ ÆÄ±«ÇÑ´Ù. »ç¿ëµÇ´Â ¹æ»ç¼±¿¡´Â ¹ÐºÀ¼Ò¼±¿ø¿¡¼ ³ª¿À´Â ¥ã¼±, Á÷¼±°¡¼Ó±â¿¡¼ ¾ò¾îÁö´Â °í¿¡³ÊÁö X¼±°ú ÀüÀÚ¼±, ÅÚ·¹ÄÚ¹ßÆ®ÀåÄ¡¿¡ ÀÇÇÑ 60CoÀÇ ¥ã¼±°ú, º£Å¸Æ®·Ð¿¡ ÀÇÇÑ ÀüÀÚ¼±, »çÀÌÅ©·ÎÆ®·Ð¿¡¼ ¾ò¾îÁö´Â ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | radiation therapy | ÇÑ±Û | ¹æ»ç¼±Ä¡·á |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼±ÀÇ »ì±ÕÈ¿°ú³ª ¼¼Æ÷¸¦ Á×ÀÌ´Â È¿°ú¸¦ Ä¡·á¿¡ ÀÌ¿ëÇÏ´Â ¹æ¹ýÀ¸·Î, Á¼Àº Àǹ̷Π¾ÏÀÇ ¹æ»ç¼±Ä¡·á¸¦ ÀǹÌÇÑ´Ù. ¾Ï¿¡ ´ëÇÑ ¹æ»ç¼±Ä¡·á´Â ¾Ï¼¼Æ÷¸¦ Á×À̴µ¥ È¿°ú°¡ Å« º£Å¸¼±À» ÁÖ·Î »ç¿ëÇÑ´Ù. ÇÏÁö¸¸, ÀÌ·± ¹æ»ç¼±Ä¡·á´Â Á¤»ó¼¼Æ÷¿¡µµ Å« ¿µÇâÀ» ³¢ÃÄ ÀÌ¿¡ µû¸¥ ±â´ÉÀÇ Àå¾Ö¸¦ °¡Á®¿Ã ¼ö ÀÖ´Ù. µû¶ó¼ ¹æ»ç¼±Ä¡·á¿¡ À־ ´ÜÁö ±× ¾Ï¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ë»Ó¸¸ ¾Æ´Ï¶ó, Á¤»ó¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ëµµ °í·ÁÇÏ¿© ½ÃÇàÇÑ´Ù. |
||
| ¿µ¹® | speech therapy | ÇÑ±Û | ¾ð¾îÄ¡·á |
|---|---|---|---|
| ¼³¸í | ¸»À» Á¤È®ÇÏ°Ô ¹ßÀ½ÇÒ ¼ö ¾ø°Å³ª ´õµë´Â ȯÀÚ¿¡°Ô ¹ßÀ½, ´ëÈ µûÀ§ÀÇ ÈÆ·ÃÀ» Àü¹®ÀûÀ¸·Î ÇàÇÏ´Â Ä¡·á¹ý. |
||
| ¿µ¹® | therapy | ÇÑ±Û | ¿ä¹ý |
|---|---|---|---|
| ¼³¸í | º´À» ³´°Ô ÇÏ´Â °Í ¶Ç´Â ±× ¹æ¹ý. |
||
| FSH/LR-RH | follicle-stimulating hormone and luteinizing hormone releasing hormone |
|---|---|
| AART | American Association for Rehabilitation Therapy; American Association for Respiratory Therapy |
| ACT | achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ... |
| ICT | icteric, icterus; indirect Coombs test; inflammation of connective tissue; insulin coma therapy; int... |
| OT | objective test; oblique talus; occlusion time; occupational therapist, occupational therapy; ocular ... |
| adrenocorticotrophic hormone | <endocrinology> A peptide hormone that is produced by the anterior pituitary gland. It stimulates the adrenal cortex to secrete glucocorticoid hormones, which help cells synthesise glucose, catabolize proteins, mobilizefree fatty acids and inhibit inflammation in allergic responses. (10 May 1997) |
|---|---|
| adrenocorticotropic hormone | The hormone of the anterior lobe of the hypophysis which governs the nutrition and growth of the adrenal cortex, stimulates it to functional activity, and also possesses extraadrenal adipokinetic activity; it is a polypeptide containing 39 amino acids, but exact structure varies from one species to another; sometimes prefixed by a to distinguish it from beta-corticotropin. The first thirteen amino acids at the N-terminal region are identical to alpha-melanotropin. Synonym: adrenocorticotropin, adrenotropic hormone, adrenotropin, corticotropic hormone, corticotropin. (05 Mar 2000) |
| adrenotropic hormone | The hormone of the anterior lobe of the hypophysis which governs the nutrition and growth of the adrenal cortex, stimulates it to functional activity, and also possesses extraadrenal adipokinetic activity; it is a polypeptide containing 39 amino acids, but exact structure varies from one species to another; sometimes prefixed by a to distinguish it from beta-corticotropin. The first thirteen amino acids at the N-terminal region are identical to alpha-melanotropin. Synonym: adrenocorticotropin, adrenotropic hormone, adrenotropin, corticotropic hormone, corticotropin. (05 Mar 2000) |
| alternative therapy | A term given to nonconventional therapy usually given by persons who do not have a medical qualification. (16 Dec 1997) |
| analytic therapy | Short term for psychoanalytic therapy. (05 Mar 2000) |
| androgenic hormone | <endocrinology> A male (masculinising) hormone. These medications (testosterone, methyltestosterone, fluoxymesterone, danazol) are used to treat androgen deficiency, delayed puberty in males and some forms of breast cancer. (27 Sep 1997) |
| anterior pituitary-like hormone | A glycoprotein with a carbohydrate fraction composed of d-galactose and hexosamine, extracted from the urine of pregnant women and produced by the placental trophoblastic cells; its most important role appears to be stimulation, during the first trimester, of ovarian secretion of the oestrogen and progesterone required for the integrity of conceptus; it appears to play no significant role in the last two trimesters of pregnancy, as the oestrogen and progesterone are then formed by the placenta. Synonym: anterior pituitary-like hormone, choriogonadotropin, chorionic gonadotropic hormone, chorionic gonadotrophic hormone, placenta gonadotropin, placentagonadotropin. (05 Mar 2000) |
| Antibody Directed Enzyme Prodrug Therapy | <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately. The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects. Acronym: ADEPT (14 Nov 1997) |
| anticoagulant therapy | The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting. (05 Mar 2000) |
| antidiuretic hormone | <endocrinology> A peptide hormone released from the posterior pituitary lobe but synthesised in the hypothalamus. There are 2 forms, differing only in the amino acid at position 8: arginine vasopressin is widespread, while lysine vasopressin is found in pigs. Has antidiuretic and vasopressor actions. Used in the treatment of diabetes insipidus. Acronym: ADH (13 Nov 1997) |
| antisense therapy | Use of antisense DNA for the inhibition of translation of a specific gene product for therapeutic purposes. (05 Mar 2000) |
| art therapy | The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioural disorders. (12 Dec 1998) |
| autoserum therapy | Therapy with serum obtained from the patient's own blood. (05 Mar 2000) |
| aversion therapy | <psychology> A form of behaviour therapy that pairs an unpleasant stimulus with undesirable behaviour(s) so that the patient learns to avoid the latter. See: aversive training. (05 Mar 2000) |
| aversive therapy | <psychology> A treatment that suppresses undesirable behaviour by simultaneously exposing the subject to unpleasant consequences. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|